Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Testosterone transdermal patch approved in Sweden

April 12, 1996

Fujisawa in-licenses zenarestat

April 12, 1996

NT-3 shows potential in diabetic neuropathy

April 12, 1996

Selective protein kinase C beta antagonist discovered by Lilly

April 12, 1996

Anergen, Novo Nordisk expand diabetes collaboration

April 12, 1996

New thiazolidinedione, MCC-555, reported by Mitsubishi Chemical

April 12, 1996

Sertoli Technologies formed to develop new technology

April 12, 1996

Gene for Werner's syndrome discovered

April 12, 1996

Conjugated estrogens + pravastatin effective in treating hypercholesterolemia in women

April 12, 1996

Vivelle U.S. launch

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 17, 2025.
Blenrep misstep? ODAC cites tox, GSK dosing neglect in MM
BioWorld
The rough ride presaged by briefing documents came to pass for GSK plc with the drug first approved by the U.S. FDA as Blenrep (belantamab mafodotin, bel-maf), as...
Atai Therapeutics discovers new 5-HT2A receptor partial agonists
BioWorld Science
Atai Therapeutics Inc. has synthesized new tetrahydro pyridine-substituted indole and azaindoles acting as 5-HT2A receptor partial agonists reported to be useful...
PHD inhibitors reported in Akebia Therapeutics patent
BioWorld Science
Akebia Therapeutics Inc. has identified new derivatives of ([1,2,4]triazolo[5,1-a]isoquinoline-5-carbonyl)glycinate acting as prolyl 4-hydroxylase (PHD) inhibitors.